| Literature DB >> 17005693 |
John J Zaunders1, Susanna Ip, Mee Ling Munier, Daniel E Kaufmann, Kazuo Suzuki, Choechoe Brereton, Sarah C Sasson, Nabila Seddiki, Kersten Koelsch, Alan Landay, Pat Grey, Robert Finlayson, John Kaldor, Eric S Rosenberg, Bruce D Walker, Barbara Fazekas de St Groth, David A Cooper, Anthony D Kelleher.
Abstract
We recently found that human immunodeficiency virus (HIV)-specific CD4+ T cells express coreceptor CCR5 and activation antigen CD38 during early primary HIV-1 infection (PHI) but then rapidly disappear from the circulation. This cell loss may be due to susceptibility to infection with HIV-1 but could also be due to inappropriate apoptosis, an expansion of T regulatory cells, trafficking out of the circulation, or dysfunction. We purified CD38+++CD4+ T cells from peripheral blood mononuclear cells, measured their level of HIV-1 DNA by PCR, and found that about 10% of this population was infected. However, a small subset of HIV-specific CD4+) T cells also expressed CD127, a marker of long-term memory cells. Purified CD127+CD4+ lymphocytes contained fivefold more copies of HIV-1 DNA per cell than did CD127-negative CD4+ cells, suggesting preferential infection of long-term memory cells. We observed no apoptosis of antigen-specific CD4+ T cells in vitro and only a small increase in CD45RO+CD25+CD127dimCD4+ T regulatory cells during PHI. However, 40% of CCR5+CD38+++ CD4+ T cells expressed gut-homing integrins, suggesting trafficking through gut-associated lymphoid tissue (GALT). Furthermore, 80% of HIV-specific CD4+ T cells expressed high levels of the negative regulator CTLA-4 in response to antigen stimulation in vitro, which was probably contributing to their inability to produce interleukin-2 and proliferate. Taken together, the loss of HIV-specific CD4+ T cells is associated with a combination of an infection of CCR5+ CD127+ memory CD4+ T cells, possibly in GALT, and a high expression of the inhibitory receptor CTLA-4.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17005693 PMCID: PMC1617311 DOI: 10.1128/JVI.00249-06
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103